课题基金 / 基金详情

Pilot & Feasibility Grant Program

Pilot & Feasibility Grant Program
飞行员
批准号：
10582232
负责人：
Holger Willenbring
金额：
$16.61万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
项目状态：
未结题
起止时间：
1996-12-01 至 2028-05-31
来源：
https://reporter.nih.gov/project-details/10582232
关键词：
Academic supportAdultAutoimmune HepatitisAwardBasic ScienceBiotechnologyCategoriesChildhoodClinicalClinical ResearchCoupledDedicationsEnsureEquilibriumFacultyFemaleFinancial SupportFundingGastroenterologyGenesGeneticGoalsGrantHepatologyIncubatorsInstitutionInvestmentsJournalsLeadershipLettersLiverLongevityMeasuresMedicineNaturePatientsPriceProcessProductivityPublicationsResearchResearch PersonnelResearch Project GrantsResourcesScientistServicesSourceTalentsTechniquesTechnologyTimeTranslational ResearchTransplant RecipientsWorkbaseclinical investigationcohortcostdiversity and equityfollow-upinnovationinterestliver transplantationmedical schoolsmembernon-alcoholic fatty liver diseaseoutreachprofessorprogramsrecruitsequencing platformsingle-cell RNA sequencingsuccesstranslational medicine

项目摘要

项目成果

Holger Willenbring的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Please refer to the Project Summary/Abstract in the OVERALL section of the application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next-generation human liver gene therapy
Next-generation human liver gene therapy
Targeting AAV vectors to cell types involved in alcohol-induced liver injury
Targeting AAV vectors to cell types involved in alcohol-induced liver injury
海外基金